Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.48%
#3 Fake World Assets Fake World Assets +4.62%
#4 Dual Dual +3.58%
#5 Figure Heloc Figure Heloc +3.49%
#6 Movement Movement +3.22%
#7 Ontology Gas Ontology Gas +2.75%
#8 HOME HOME +2.62%
#9 The Black Bull The Black Bull +2.59%
#10 Orochi Network Orochi Network +2.47%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Classement en actions #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Prix de l'action
$0.00953895
Dernière synchronisation: 2024-05-22
Capitalisation boursière
$1.28M
Changement (1 jour)
0.06%
Changement (1 an)
0.00%
Pays
GB
Échange Evgen Pharma plc (EVG)

Catégorie

Healthcare
Ratio P/B pour Evgen Pharma plc (EVG)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Evgen Pharma plc, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Evgen Pharma plc de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE